Cafepharma Today

January 17 2025 - Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy
Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy
AstraZeneca overhauls management of its scandal-hit China division
Lykos still plotting path to approval for rejected MDMA therapy after 'productive' FDA meeting
Ozempic tops new Medicare price negotiation list
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Biovail Comments On Filing Of Lawsuit
Medical News Today
Sunday, October 12, 2008 - 11:05am
tags:
Inspire Initiates Phase 1 Trial Of INS117548 For Glaucoma
Medical News Today
Sunday, October 12, 2008 - 11:04am
tags:
Plenty of Hope and Hype Behind California's $3 Billion Stem Cell Research Program
Red Orbit
Sunday, October 12, 2008 - 10:58am
tags:
Celtic Catalysts raises €500,000 in fresh funding
Sunday Business Post, Ireland
Sunday, October 12, 2008 - 10:53am
tags:
NeoBiocon and Abraxis BioScience Launch Abraxane in The UAE for Treatment of Breast Cancer
Nanotechnology Now
Saturday, October 11, 2008 - 12:21pm
tags:
FDA delay puts PPD payment on hold
San Antonio Business Journal, TX
Saturday, October 11, 2008 - 12:19pm
tags:
Pharma cos (in India) may report 23.4% revenue growth for Q2: Sharekhan
My Iris, India
Saturday, October 11, 2008 - 12:18pm
tags:
Biotech, drug stocks drop to 52-week lows
San Diego Tribune, CA
Saturday, October 11, 2008 - 12:11pm
tags:
Wockhardt Inks Licensing Pact With UK-Based Sinclair Pharma
Top News, India
Saturday, October 11, 2008 - 12:07pm
tags:
Alabama settles suits against 5 drug companies
Yahoo/AP
Saturday, October 11, 2008 - 12:06pm
tags:
J&J a Buy in Current Climate
Yahoo/Zacks
Saturday, October 11, 2008 - 12:06pm
tags:
US court affirms bar on Roche anemia drug launch
Yahoo/AP
Saturday, October 11, 2008 - 12:04pm
tags:
The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Medicis Pharmaceutical Corporation
Yahoo
Saturday, October 11, 2008 - 12:04pm
tags:
FDA Continues Review Of Takeda's New Drug Application For Alogliptin (SYR-322), A DPP-4 Agent For Type 2 Diabetes
Medical News Today
Saturday, October 11, 2008 - 12:02pm
tags:
Angiotech's corporate partner, Boston Scientific, announces FDA approval of second-generation TAXUS(R) Liberté(R) drug-eluting stent
CNW Telbec
Saturday, October 11, 2008 - 12:01pm
tags:
When There Is Blood In The Streets - Buy Biotech
istockanalyst
Saturday, October 11, 2008 - 11:57am
tags:
Lorus Therapeutics Announces Voluntary Delisting From the NYSE
IT Business Net
Saturday, October 11, 2008 - 11:56am
tags:
Eli Lilly's Lesson in Long-Term Thinking
The Street
Saturday, October 11, 2008 - 11:51am
tags:
ImClone vs. GM — No Contest on Market Capitalization
Wall Street Journal
Saturday, October 11, 2008 - 11:50am
tags:
Investors Overreacting to Biogen Choice?
Yahoo
Saturday, October 11, 2008 - 11:48am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

2025 Brand Drug Challenges: A GoodRx Perspective
Drug Channels
Snake Antivenoms, Computed
In the Pipeline
Versatile Chaperones
In the Pipeline
Dealing With Being a Tumor Cell
In the Pipeline
Why 340B Reform Could Happen in 2025 (video)
Drug Channels
Drug Channels Leadership Forum: Request an Invitation Before It’s Too Late!
Drug Channels
The Pain Comes With the Territory
In the Pipeline
A New Antiviral Target, On the Host Side
In the Pipeline
Inside a Fentanyl Kitchen
In the Pipeline

Latest Jobs

Account Executive
McAlester, Oklahoma, 74502
Elara Caring
Account Executive
San Antonio, Texas, 78284
Elara Caring
Account Executive
Wichita Falls, Texas, 76309
Elara Caring
Account Executive
Dallas, Texas, 75219
Elara Caring
Account Executive, Home Health
Austin, Texas, 78703
AccentCare, Inc.
Account Executive
Monroe, Louisiana, 71201
Elara Caring
Account Executive
Clinton Township, Michigan, 48036
Elara Caring
Sales Representative- Wilmington/Harrisburg- Communications
Lancaster, Pennsylvania, 17699
Stryker
Sales Representative- Southern MD- Communications
Washington, District of Columbia, 20080
Stryker
Account Executive, Home Health
Temple, Texas, 76504
AccentCare, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information